Despite ongoing controversies about the relative abundance and specificity of these markers [19–21], CD133+ brain tumor stem cells are chemotherapy- and radiation-resistant [13, 22], and their frequency correlates with adverse survival in adult glioma [23]. The gene discussed is PROM1; the disease is brain neoplasm.